Komori
Governance4576D.Western Therapeutics Institute, Inc.Pharmaceuticals

Notice Regarding the Application to Change Market Segments to the Standard Market of the Tokyo Stock Exchange

The Board of Directors resolved to apply to change the Tokyo Stock Exchange market segment from the Growth Market to the Standard Market. Approval and the timing of the change have not yet been determined.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Contents of this filing

Changes this time

The Board of Directors resolved to apply to change the Tokyo Stock Exchange market segment from the Growth Market to the Standard Market.

この書類は、機関設計や取締役会の構成そのものは述べていません。上に示したのは、この書類が述べている変更点です。

Contents of this filing
ItemDetails
Changes this timeThe Board of Directors resolved to apply to change the Tokyo Stock Exchange market segment from the Growth Market to the Standard Market.
Items this document does not state (7)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company determined that operating in a market environment better suited to its current business stage and future growth strategy is important for advancing its medium- to long-term growth strategy and sustainably increasing corporate value.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Application to Change Market Segments to the Standard Market of the Tokyo Stock Exchange | D.Western Therapeutics Institute, Inc. (4576) timely disclosure | Komori